<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ocular drug delivery &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/ocular-drug-delivery/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 16 Oct 2026 19:56:40 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>ocular drug delivery &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Lipid Nanoparticles Could Turn Ordinary Eye Drops Into Powerful Precision Therapies</title>
		<link>https://bioengineer.org/lipid-nanoparticles-could-turn-ordinary-eye-drops-into-powerful-precision-therapies/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 16 Oct 2026 19:56:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[corneal permeation]]></category>
		<category><![CDATA[cubosomes]]></category>
		<category><![CDATA[drug bioavailability]]></category>
		<category><![CDATA[dry eye]]></category>
		<category><![CDATA[glaucoma]]></category>
		<category><![CDATA[liposomes]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[nanoparticles]]></category>
		<category><![CDATA[ocular drug delivery]]></category>
		<category><![CDATA[Ophthalmology]]></category>
		<category><![CDATA[solid lipid nanoparticles]]></category>
		<category><![CDATA[tear film]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=423728</guid>

					<description><![CDATA[A new review details how liposomes, cubosomes, and solid lipid nanoparticles are overcoming the eye's formidable barriers to deliver drugs more effectively through simple eye drops.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">423728</post-id>	</item>
		<item>
		<title>Cholesterol Drug Fenofibrate Emerges as a Surprising Candidate Against Blinding Eye Disease</title>
		<link>https://bioengineer.org/cholesterol-drug-fenofibrate-emerges-as-a-surprising-candidate-against-blinding-eye-disease/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 16 Oct 2026 19:12:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Age-related macular degeneration]]></category>
		<category><![CDATA[diabetic corneal neuropathy]]></category>
		<category><![CDATA[diabetic macular edema]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Drug repurposing]]></category>
		<category><![CDATA[dry eye disease]]></category>
		<category><![CDATA[fenofibrate]]></category>
		<category><![CDATA[LENS trial]]></category>
		<category><![CDATA[Mitochondrial dysfunction]]></category>
		<category><![CDATA[NF-kB signaling]]></category>
		<category><![CDATA[ocular drug delivery]]></category>
		<category><![CDATA[PPAR alpha]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=423171</guid>

					<description><![CDATA[A comprehensive review finds that the lipid-lowering drug fenofibrate shows strong clinical evidence for slowing diabetic retinopathy and promising preclinical potential across corneal and retinal diseases.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">423171</post-id>	</item>
	</channel>
</rss>
